Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Dermatologists greatly affect inpatient diagnosis and treatment of skin conditions, especially in spotting infections in patients with weakened immune systems.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Injectable cryogels can deliver drugs and aid tissue repair with minimal surgery.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

Scalp cooling helps prevent hair loss during certain breast cancer treatments, especially when anthracyclines aren't used.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Sphaeranthus indicus and silver nanoparticles can help treat liver cancer by killing cancer cells.

GSDMA deficiency slows skin cancer growth.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Early detection and treatment of iron deficiency anemia, especially in premenopausal women, is crucial for rapid symptom improvement.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

PEH in vulvar LS is common and needs careful diagnosis to avoid confusion with cancer.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.

Nilotinib can cause keratosis pilaris, a skin condition.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Zinc and biotin supplements are needed after certain surgeries to prevent hair loss and other issues.

The document emphasizes standardized, comprehensive training for dermatology and venereology specialists across Europe.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.